Anatomical characteristics of the left atrial appendage in cardiogenic stroke with low CHADS2 scores.

[1]  Sanghamitra Mohanty,et al.  Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. , 2012, Journal of the American College of Cardiology.

[2]  Kenneth A Ellenbogen,et al.  2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2011, Circulation.

[3]  Jeremy N Ruskin,et al.  Left Atrial Appendage Dimensions Predict the Risk of Stroke/TIA in Patients With Atrial Fibrillation , 2011, Journal of cardiovascular electrophysiology.

[4]  M. Ezekowitz,et al.  on Practice Guidelines of Cardiology Foundation Foundation/American Heart Association Task Force Atrial Fibrillation (Update on Dabigatran): A Report of the American College 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With , 2011 .

[5]  Kenneth A Ellenbogen,et al.  2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2011, Journal of the American College of Cardiology.

[6]  Yan Wang,et al.  Left Atrial Appendage Studied by Computed Tomography to Help Planning for Appendage Closure Device Placement , 2010, Journal of cardiovascular electrophysiology.

[7]  M. Rosenqvist,et al.  Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation. , 2010, European heart journal.

[8]  Maurice Buchbinder,et al.  Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial , 2009, The Lancet.

[9]  M. Hirai,et al.  Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM Study. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[10]  Timothy Watson,et al.  Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited , 2009, The Lancet.

[11]  Thomas H Mosley,et al.  The Predictive Value of Left Atrial Size for Incident Ischemic Stroke and All-Cause Mortality in African Americans: The Atherosclerosis Risk in Communities (ARIC) Study , 2008, Stroke.

[12]  D. Singer,et al.  Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation. , 2008, Journal of the American College of Cardiology.

[13]  R. Devereux,et al.  Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the Strong Heart Study (SHS). , 2006, American heart journal.

[14]  Darin Okerlund,et al.  Feasibility and validation of registration of three-dimensional left atrial models derived from computed tomography with a noncontact cardiac mapping system. , 2005, Heart rhythm.

[15]  Yuchiao Chang,et al.  Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? , 2003, JAMA.

[16]  Martha J. Radford,et al.  Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation , 2001 .

[17]  J. Halperin,et al.  Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators. , 1998, Journal of the American College of Cardiology.

[18]  P. Wolf,et al.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.